首页 > 最新文献

Medicina de Familia-SEMERGEN最新文献

英文 中文
Disnea en el anciano, más allá de lo típico 在老人的Disnia,超越了典型的
IF 0.9 Q4 PRIMARY HEALTH CARE Pub Date : 2025-11-01 Epub Date: 2025-05-22 DOI: 10.1016/j.semerg.2025.102520
L. Hernández-Camacho , M.E. Charte Alegre , M. Lalueza Cosculluela , A. Fournier Bedoya , A.B. Solano Checa
{"title":"Disnea en el anciano, más allá de lo típico","authors":"L. Hernández-Camacho , M.E. Charte Alegre , M. Lalueza Cosculluela , A. Fournier Bedoya , A.B. Solano Checa","doi":"10.1016/j.semerg.2025.102520","DOIUrl":"10.1016/j.semerg.2025.102520","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 8","pages":"Article 102520"},"PeriodicalIF":0.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144115533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uso de la Unidad de Rehabilitación del Equilibrio (URE) en disfunciones vestibulares: revisión sistemática sobre su aplicación diagnóstica y terapéutica 在前庭功能障碍中使用平衡康复单位:对其诊断和治疗应用进行系统审查
IF 0.9 Q4 PRIMARY HEALTH CARE Pub Date : 2025-11-01 Epub Date: 2025-09-22 DOI: 10.1016/j.semerg.2025.102568
M. Jara , S.V. Flores , R. Montaña , Á. Roco-Videla
The Balance Rehabilitation Unit (BRU) has emerged as a promising tool for the evaluation and treatment of vestibular dysfunctions. In this context, the present study analyzed scientific evidence regarding its clinical use through a systematic review guided by PRISMA guidelines. In most of the studies (80%), the BRU was used to assess center of pressure (COP) and sway velocity (SV), showing significant improvements after the interventions. Furthermore, when compared to conventional treatments, it demonstrated superior results in these parameters, reinforcing its value in rehabilitation. However, the absence of normative values limits its diagnostic application, highlighting the need for further research to establish clear reference parameters that can guide its clinical use.
平衡康复单元(BRU)已成为评估和治疗前庭功能障碍的一种有前途的工具。在此背景下,本研究通过PRISMA指南指导下的系统评价,分析了有关其临床应用的科学证据。在大多数研究中(80%),BRU被用来评估压力中心(COP)和摇摆速度(SV),在干预后显示出显著的改善。此外,与常规治疗相比,它在这些参数上表现出更好的结果,加强了它在康复中的价值。然而,缺乏规范性值限制了其诊断应用,强调需要进一步研究,以建立明确的参考参数,可以指导其临床应用。
{"title":"Uso de la Unidad de Rehabilitación del Equilibrio (URE) en disfunciones vestibulares: revisión sistemática sobre su aplicación diagnóstica y terapéutica","authors":"M. Jara ,&nbsp;S.V. Flores ,&nbsp;R. Montaña ,&nbsp;Á. Roco-Videla","doi":"10.1016/j.semerg.2025.102568","DOIUrl":"10.1016/j.semerg.2025.102568","url":null,"abstract":"<div><div>The Balance Rehabilitation Unit (BRU) has emerged as a promising tool for the evaluation and treatment of vestibular dysfunctions. In this context, the present study analyzed scientific evidence regarding its clinical use through a systematic review guided by PRISMA guidelines. In most of the studies (80%), the BRU was used to assess center of pressure (COP) and sway velocity (SV), showing significant improvements after the interventions. Furthermore, when compared to conventional treatments, it demonstrated superior results in these parameters, reinforcing its value in rehabilitation. However, the absence of normative values limits its diagnostic application, highlighting the need for further research to establish clear reference parameters that can guide its clinical use.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 8","pages":"Article 102568"},"PeriodicalIF":0.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145120827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aceite y vida: el impacto del aceite de oliva en la salud humana. Revisión de la evidencia de la recomendación del uso del aceite de oliva virgen extra 橄榄油与生命:橄榄油对人类健康的影响。对建议使用特级初榨橄榄油的证据进行审查
IF 0.9 Q4 PRIMARY HEALTH CARE Pub Date : 2025-11-01 Epub Date: 2025-09-09 DOI: 10.1016/j.semerg.2025.102582
J.M. Rubio López
Extra virgin olive oil (EVOO) is a key functional food in the Mediterranean diet, renowned for its multiple health benefits. Rich in monounsaturated fatty acids, such as oleic acid, and bioactive compounds like polyphenols and tocopherols, EVOO helps reduce LDL cholesterol, increase HDL cholesterol, and protect against oxidative stress. Regular consumption is associated with a lower incidence of cardiovascular, metabolic, and neurodegenerative diseases. Studies such as PREDIMED and the Seven Countries Study have demonstrated its role in preventing cardiovascular events and reducing blood pressure. Additionally, EVOO contributes to cancer prevention, lowering the risk of specific types like breast and colon cancer. It also improves insulin sensitivity and intestinal microbiota health, promoting metabolic and cognitive balance. Recommended for its positive impact on health, EVOO should be a staple in a healthy daily diet, not only as a substitute for saturated fats but as an essential ingredient to enhance quality of life and prevent chronic diseases.
The information search period covers the years 2000 to April 2025, in accordance with the inclusion criteria defined for the studies. These criteria prioritize relevant and up-to-date publications, while allowing exceptions for earlier works of historical significance.
特级初榨橄榄油(EVOO)是地中海饮食中重要的功能性食品,因其多种健康益处而闻名。富含单不饱和脂肪酸,如油酸,和生物活性化合物,如多酚和生育酚,EVOO有助于降低低密度脂蛋白胆固醇,增加高密度脂蛋白胆固醇,并防止氧化应激。经常消费与心血管、代谢和神经退行性疾病的发病率较低有关。PREDIMED和七国研究等研究已经证明了它在预防心血管事件和降低血压方面的作用。此外,EVOO有助于预防癌症,降低乳腺癌和结肠癌等特定类型的风险。它还能改善胰岛素敏感性和肠道菌群健康,促进代谢和认知平衡。因其对健康的积极影响,EVOO应成为健康日常饮食的主食,不仅作为饱和脂肪的替代品,而且作为提高生活质量和预防慢性疾病的必要成分。根据为研究确定的纳入标准,资料检索期为2000年至2025年4月。这些标准优先考虑相关和最新的出版物,同时允许有历史意义的早期作品例外。
{"title":"Aceite y vida: el impacto del aceite de oliva en la salud humana. Revisión de la evidencia de la recomendación del uso del aceite de oliva virgen extra","authors":"J.M. Rubio López","doi":"10.1016/j.semerg.2025.102582","DOIUrl":"10.1016/j.semerg.2025.102582","url":null,"abstract":"<div><div>Extra virgin olive oil (EVOO) is a key functional food in the Mediterranean diet, renowned for its multiple health benefits. Rich in monounsaturated fatty acids, such as oleic acid, and bioactive compounds like polyphenols and tocopherols, EVOO helps reduce LDL cholesterol, increase HDL cholesterol, and protect against oxidative stress. Regular consumption is associated with a lower incidence of cardiovascular, metabolic, and neurodegenerative diseases. Studies such as PREDIMED and the Seven Countries Study have demonstrated its role in preventing cardiovascular events and reducing blood pressure. Additionally, EVOO contributes to cancer prevention, lowering the risk of specific types like breast and colon cancer. It also improves insulin sensitivity and intestinal microbiota health, promoting metabolic and cognitive balance. Recommended for its positive impact on health, EVOO should be a staple in a healthy daily diet, not only as a substitute for saturated fats but as an essential ingredient to enhance quality of life and prevent chronic diseases.</div><div>The information search period covers the years 2000 to April 2025, in accordance with the inclusion criteria defined for the studies. These criteria prioritize relevant and up-to-date publications, while allowing exceptions for earlier works of historical significance.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 8","pages":"Article 102582"},"PeriodicalIF":0.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145018696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Grado de satisfacción de infiltraciones articulares en atención primaria 初级保健中关节浸润的满意度
IF 0.9 Q4 PRIMARY HEALTH CARE Pub Date : 2025-11-01 Epub Date: 2025-07-14 DOI: 10.1016/j.semerg.2025.102554
R. Damián-García , A. Relaño-Mesa , E. Martín-Riobóo

Objective

The main objective of this study is to evaluate the level of patient satisfaction after joint injections with corticosteroids and local anesthetics in Primary Care (PC). Secondarily, we pretend to analyze the sociodemographic characteristics of the sample, the frequency of injected joints, adverse effects, analgesia used at least 30 days, the imaging tests performed, and the primary diagnoses leading to injections.

Material and methods

Observational, descriptive, longitudinal, and prospective study. The estimated sample size was 64 subjects. Absolute values and frequencies were calculated for qualitative variables (sociodemographic variables, anatomical regions infiltrated, additional tests, analgesia used at least 30 days, adverse effects, level of satisfaction four weeks after the procedure, and the possibility of re-infiltration if pain in the same or a different anatomical area occurs), as well as means and standard deviations for quantitative variables (sociodemographic variables). To determine the level of pain in the anatomical region to be infiltrated, a verbal numeric rating scale (VRNS) was used before the procedure, as well as two and four weeks afterward. Patient satisfaction was determined using an ad hoc scale with five possible options (none, minimal, acceptable, high, very high) four weeks after the procedure.

Results

The satisfaction with the procedure in this study was very high (53.8%) or high (24.6%). 90.8% of patients indicated they would repeat local injections with local anesthetic and corticosteroids again. If they needed to repeat any injection again, 86.2% would do it in primary care. The knee was injected in 41.5% of cases, and in 36.9% of cases, for the diagnosis of gonarthrosis.

Conclusion

Pain in the affected region decreased from severe to mild one month after the procedure, resulting in a very high level of satisfaction. The high level of patient satisfaction with this health program justifies its use at primary care centers.
目的本研究的主要目的是评估初级保健(PC)联合注射皮质类固醇和局麻药后患者的满意度。其次,我们试图分析样本的社会人口学特征、注射关节的频率、不良反应、至少使用30天的镇痛药、进行的影像学检查以及导致注射的初步诊断。材料和方法:观察性、描述性、纵向和前瞻性研究。估计样本量为64名受试者。计算了定性变量(社会人口变量、浸润的解剖区域、额外的测试、至少使用30天的镇痛药、不良反应、手术后四周的满意度、如果在同一或不同解剖区域发生疼痛时再次浸润的可能性)的绝对值和频率,以及定量变量(社会人口变量)的平均值和标准差。为了确定要浸润的解剖区域的疼痛程度,在手术前以及手术后两周和四周使用口头数字评定量表(VRNS)。在手术后四周,使用一个特设量表来确定患者满意度,该量表有五种可能的选择(无、最低、可接受、高、非常高)。结果本组患者对手术的满意度为非常高(53.8%)和高(24.6%)。90.8%的患者表示会再次局部注射局麻和皮质激素。如果他们需要再次注射,86.2%的人会在初级保健中这样做。41.5%的病例和36.9%的病例在诊断关节病时进行了膝关节注射。结论术后1个月患区疼痛由重度减轻到轻度,患者满意度很高。病人对这个健康项目的高满意度证明了在初级保健中心使用它是合理的。
{"title":"Grado de satisfacción de infiltraciones articulares en atención primaria","authors":"R. Damián-García ,&nbsp;A. Relaño-Mesa ,&nbsp;E. Martín-Riobóo","doi":"10.1016/j.semerg.2025.102554","DOIUrl":"10.1016/j.semerg.2025.102554","url":null,"abstract":"<div><h3>Objective</h3><div>The main objective of this study is to evaluate the level of patient satisfaction after joint injections with corticosteroids and local anesthetics in Primary Care (PC). Secondarily, we pretend to analyze the sociodemographic characteristics of the sample, the frequency of injected joints, adverse effects, analgesia used at least 30<!--> <!-->days, the imaging tests performed, and the primary diagnoses leading to injections.</div></div><div><h3>Material and methods</h3><div>Observational, descriptive, longitudinal, and prospective study. The estimated sample size was 64 subjects. Absolute values and frequencies were calculated for qualitative variables (sociodemographic variables, anatomical regions infiltrated, additional tests, analgesia used at least 30<!--> <!-->days, adverse effects, level of satisfaction four weeks after the procedure, and the possibility of re-infiltration if pain in the same or a different anatomical area occurs), as well as means and standard deviations for quantitative variables (sociodemographic variables). To determine the level of pain in the anatomical region to be infiltrated, a verbal numeric rating scale (VRNS) was used before the procedure, as well as two and four weeks afterward. Patient satisfaction was determined using an ad hoc scale with five possible options (none, minimal, acceptable, high, very high) four weeks after the procedure.</div></div><div><h3>Results</h3><div>The satisfaction with the procedure in this study was very high (53.8%) or high (24.6%). 90.8% of patients indicated they would repeat local injections with local anesthetic and corticosteroids again. If they needed to repeat any injection again, 86.2% would do it in primary care. The knee was injected in 41.5% of cases, and in 36.9% of cases, for the diagnosis of gonarthrosis.</div></div><div><h3>Conclusion</h3><div>Pain in the affected region decreased from severe to mild one month after the procedure, resulting in a very high level of satisfaction. The high level of patient satisfaction with this health program justifies its use at primary care centers.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 8","pages":"Article 102554"},"PeriodicalIF":0.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144614184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lesiones en zonas fotoexpuestas: el papel de la atención primaria en el diagnóstico diferencial 光照射区损伤:初级保健在鉴别诊断中的作用
IF 0.9 Q4 PRIMARY HEALTH CARE Pub Date : 2025-11-01 Epub Date: 2025-05-22 DOI: 10.1016/j.semerg.2025.102491
J. González Fernández , M. García García , M. Ara Martín
{"title":"Lesiones en zonas fotoexpuestas: el papel de la atención primaria en el diagnóstico diferencial","authors":"J. González Fernández ,&nbsp;M. García García ,&nbsp;M. Ara Martín","doi":"10.1016/j.semerg.2025.102491","DOIUrl":"10.1016/j.semerg.2025.102491","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 8","pages":"Article 102491"},"PeriodicalIF":0.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144115534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fronteras 边界
IF 0.9 Q4 PRIMARY HEALTH CARE Pub Date : 2025-11-01 Epub Date: 2025-05-10 DOI: 10.1016/j.semerg.2025.102521
M. Lalueza Cosculluela
{"title":"Fronteras","authors":"M. Lalueza Cosculluela","doi":"10.1016/j.semerg.2025.102521","DOIUrl":"10.1016/j.semerg.2025.102521","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 8","pages":"Article 102521"},"PeriodicalIF":0.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143932193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiología, características y gestión de la enfermedad renal crónica asociada a la diabetes en un área sanitaria de Cádiz [在健康地区与糖尿病相关的慢性肾脏疾病的流行病学、特征和管理Cádiz]。
IF 0.9 Q4 PRIMARY HEALTH CARE Pub Date : 2025-11-01 Epub Date: 2025-09-18 DOI: 10.1016/j.semerg.2025.102584
J. Escribano-Serrano , E. Jiménez-Varo , M. Escribano-Cobalea , C. Casto-Jarillo , A. López-Ceres , E. Campos-Dávila , A. Hormigo-Pozo , C. Nieto-Ordoñez , M.Á. Rodríguez-Juliá , A. Michán-Doña

Introduction

Chronic Kidney Disease associated with Diabetes Mellitus (CKD-DM) is a prevalent condition with significant morbidity, mortality, and healthcare burden. Despite its relevance, its specific characteristics within the Spanish context have been scarcely described.

Objective

To determine the prevalence, clinical phenotypes, and therapeutic management of CKD-DM according to KDIGO guidelines in a healthcare area in southern Spain.

Methods

Observational, cross-sectional, and retrospective study based on SIDICAM records from July 2021 to June 2023 in the Campo de Gibraltar East Health Management Area. Diabetic patients (PDM) were identified and classified according to KDIGO 2024 criteria: estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR).

Results

Among the 8,732 PDM analyzed, 32.3% had CKD-DM (95% CI: 31.3%-33.2%), and 6.9% met criteria for nephrology-range CKD-DM. The predominant phenotype was eGFR < 60 mL/min/1.73 m2 (14.2%), followed by the combined phenotype (9.2%) and isolated albuminuria (8.9%). Prevalence was higher in women and increased with age and diabetes duration. SGLT2 inhibitors were used in 48% of patients with CKD-DM, rising to 60% among the youngest group.

Conclusion

CKD-DM shows a high prevalence and phenotypic variability according to age, sex, and diabetes progression. This study highlights the need for personalized preventive and therapeutic strategies, as well as the crucial role that primary care must play in the early detection and management of CKD-DM.
慢性肾脏疾病合并糖尿病(CKD-DM)是一种具有显著发病率、死亡率和医疗负担的常见病。尽管它具有相关性,但它在西班牙背景下的具体特点却很少得到描述。目的:根据西班牙南部某医疗保健地区的KDIGO指南,确定CKD-DM的患病率、临床表型和治疗管理。方法:基于2021年7月至2023年6月在Campo de Gibraltar East卫生管理区的SIDICAM记录进行观察性、横断面和回顾性研究。糖尿病患者(PDM)根据KDIGO 2024标准进行识别和分类:估计肾小球滤过率(eGFR)和白蛋白与肌酐比(ACR)。结果:在分析的8732例PDM中,32.3%患有CKD-DM (95% CI: 31.3%-33.2%), 6.9%符合肾脏学范围的CKD-DM标准。主要表型为eGFR 2(14.2%),其次为联合表型(9.2%)和分离性蛋白尿(8.9%)。女性患病率较高,且随年龄和糖尿病病程增加而增加。48%的CKD-DM患者使用SGLT2抑制剂,在最年轻的一组中上升到60%。结论:CKD-DM根据年龄、性别和糖尿病进展表现出较高的患病率和表型变异性。这项研究强调了个性化预防和治疗策略的必要性,以及初级保健在CKD-DM的早期发现和管理中必须发挥的关键作用。
{"title":"Epidemiología, características y gestión de la enfermedad renal crónica asociada a la diabetes en un área sanitaria de Cádiz","authors":"J. Escribano-Serrano ,&nbsp;E. Jiménez-Varo ,&nbsp;M. Escribano-Cobalea ,&nbsp;C. Casto-Jarillo ,&nbsp;A. López-Ceres ,&nbsp;E. Campos-Dávila ,&nbsp;A. Hormigo-Pozo ,&nbsp;C. Nieto-Ordoñez ,&nbsp;M.Á. Rodríguez-Juliá ,&nbsp;A. Michán-Doña","doi":"10.1016/j.semerg.2025.102584","DOIUrl":"10.1016/j.semerg.2025.102584","url":null,"abstract":"<div><h3>Introduction</h3><div>Chronic Kidney Disease associated with Diabetes Mellitus (CKD-DM) is a prevalent condition with significant morbidity, mortality, and healthcare burden. Despite its relevance, its specific characteristics within the Spanish context have been scarcely described.</div></div><div><h3>Objective</h3><div>To determine the prevalence, clinical phenotypes, and therapeutic management of CKD-DM according to KDIGO guidelines in a healthcare area in southern Spain.</div></div><div><h3>Methods</h3><div>Observational, cross-sectional, and retrospective study based on SIDICAM records from July 2021 to June 2023 in the Campo de Gibraltar East Health Management Area. Diabetic patients (PDM) were identified and classified according to KDIGO 2024 criteria: estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR).</div></div><div><h3>Results</h3><div>Among the 8,732 PDM analyzed, 32.3% had CKD-DM (95% <span>C</span>I: 31.3%-33.2%), and 6.9% met criteria for nephrology-range CKD-DM. The predominant phenotype was eGFR &lt;<!--> <!-->60<!--> <!-->mL/min/1.73 m<sup>2</sup> (14.2%), followed by the combined phenotype (9.2%) and isolated albuminuria (8.9%). Prevalence was higher in women and increased with age and diabetes duration. SGLT2 inhibitors were used in 48% of patients with CKD-DM, rising to 60% among the youngest group.</div></div><div><h3>Conclusion</h3><div>CKD-DM shows a high prevalence and phenotypic variability according to age, sex, and diabetes progression. This study highlights the need for personalized preventive and therapeutic strategies, as well as the crucial role that primary care must play in the early detection and management of CKD-DM.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 8","pages":"Article 102584"},"PeriodicalIF":0.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145093212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cocaine-induced plasma cell orificial dermatomucositis 可卡因致浆细胞口源性皮肤粘膜炎
IF 0.9 Q4 PRIMARY HEALTH CARE Pub Date : 2025-11-01 Epub Date: 2025-07-14 DOI: 10.1016/j.semerg.2025.102557
M. Mansilla-Polo , F. Reyes-Albaladejo , R. Botella-Estrada
{"title":"Cocaine-induced plasma cell orificial dermatomucositis","authors":"M. Mansilla-Polo ,&nbsp;F. Reyes-Albaladejo ,&nbsp;R. Botella-Estrada","doi":"10.1016/j.semerg.2025.102557","DOIUrl":"10.1016/j.semerg.2025.102557","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 8","pages":"Article 102557"},"PeriodicalIF":0.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144614186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimación de grasa corporal de una población con diabetes de un área de salud mediante fórmula Clínica Universitaria de Navarra-Body Adiposity Estimator [CUN-BAE] 使用纳瓦拉大学临床-身体脂肪估算器公式估算某保健地区糖尿病患者的体脂
IF 0.9 Q4 PRIMARY HEALTH CARE Pub Date : 2025-10-01 Epub Date: 2025-07-22 DOI: 10.1016/j.semerg.2025.102548
J.M. Iturralde-Iriso , J. Guinea-Castanares , I.N. Elizondo-Pinillos

Objective

To perform a descriptive analysis of a population diagnosed with DM2 in Alava, to correlate the CUN-BAE and BMI formulas and to analyse the use of GLP-1 analogue.

Materials and methods

This is a descriptive, cross-sectional, retrospective and observational study. We included the type 2 diabetic population of Alava, over 18 years of age with BMI recorded in their clinical history in the last 2 years, the data were collected from the OBID database.

Results

1,3705 patients were analysed, 56.4% men and 43.6% women. The mean age was 69.18 years. Mean BMI in men was 29.12 (SD 4.79) kg/m2 and in women 29.88 (SD 6) kg/m2. The CUN-BAE in men was 32.15 (SD 5.29) and in women 44.29 (SD 5.5).

Conclusions

41% of the population analysed by BMI would be considered obese, while with CUN-BAE 95.2% of men and 93.2% of women would be considered obese. Further studies are needed to make a more accurate estimation with CUN-BAE in other breeds.
目的对Alava诊断为DM2的人群进行描述性分析,以关联con - bae和BMI公式,并分析GLP-1类似物的使用。材料与方法这是一项描述性、横断面、回顾性和观察性研究。我们纳入了Alava的2型糖尿病人群,年龄在18岁以上,近2年的临床病史中有BMI记录,数据来自OBID数据库。结果共分析13705例患者,其中男性56.4%,女性43.6%。平均年龄69.18岁。男性的平均BMI为29.12 (SD 4.79) kg/m2,女性为29.88 (SD 6) kg/m2。男性的con - bae为32.15 (SD 5.29),女性为44.29 (SD 5.5)。结论BMI分析人群中有41%的人被认为是肥胖,而un - bae分析人群中有95.2%的男性和93.2%的女性被认为是肥胖。需要进一步的研究来对其他品种的con - bae进行更准确的估计。
{"title":"Estimación de grasa corporal de una población con diabetes de un área de salud mediante fórmula Clínica Universitaria de Navarra-Body Adiposity Estimator [CUN-BAE]","authors":"J.M. Iturralde-Iriso ,&nbsp;J. Guinea-Castanares ,&nbsp;I.N. Elizondo-Pinillos","doi":"10.1016/j.semerg.2025.102548","DOIUrl":"10.1016/j.semerg.2025.102548","url":null,"abstract":"<div><h3>Objective</h3><div>To perform a descriptive analysis of a population diagnosed with DM2 in Alava, to correlate the CUN-BAE and BMI formulas and to analyse the use of GLP-1 analogue.</div></div><div><h3>Materials and methods</h3><div>This is a descriptive, cross-sectional, retrospective and observational study. We included the type 2 diabetic population of Alava, over 18 years of age with BMI recorded in their clinical history in the last 2 years, the data were collected from the OBID database.</div></div><div><h3>Results</h3><div>1,3705 patients were analysed, 56.4% men and 43.6% women. The mean age was 69.18 years. Mean BMI in men was 29.12 (SD 4.79) kg/m2 and in women 29.88 (SD 6) kg/m2. The CUN-BAE in men was 32.15 (SD 5.29) and in women 44.29 (SD 5.5).</div></div><div><h3>Conclusions</h3><div>41% of the population analysed by BMI would be considered obese, while with CUN-BAE 95.2% of men and 93.2% of women would be considered obese. Further studies are needed to make a more accurate estimation with CUN-BAE in other breeds.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 7","pages":"Article 102548"},"PeriodicalIF":0.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144678946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Desmitificando el diagnóstico de las ITS: una mirada crítica desde una perspectiva de género; ¿existe discriminación o prejuicios? 消除性传播疾病诊断的神秘性:从性别角度进行批判;是否存在歧视或偏见?
IF 0.9 Q4 PRIMARY HEALTH CARE Pub Date : 2025-10-01 Epub Date: 2025-06-30 DOI: 10.1016/j.semerg.2025.102551
H. Bermúdez Marval, C. García Bertolín, A. Rojas Díaz, T. Arroyo Serrano, M. Linares Rufo
{"title":"Desmitificando el diagnóstico de las ITS: una mirada crítica desde una perspectiva de género; ¿existe discriminación o prejuicios?","authors":"H. Bermúdez Marval,&nbsp;C. García Bertolín,&nbsp;A. Rojas Díaz,&nbsp;T. Arroyo Serrano,&nbsp;M. Linares Rufo","doi":"10.1016/j.semerg.2025.102551","DOIUrl":"10.1016/j.semerg.2025.102551","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 7","pages":"Article 102551"},"PeriodicalIF":0.9,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144513498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicina de Familia-SEMERGEN
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1